Sartorius Aktiengesellschaft (SRT) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.049x

Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Sartorius Aktiengesellschaft to measure how many days the company can operate on defensive assets alone.

Sartorius Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Wan Hai Lines Ltd
TW:2615
0.038x
Telekom Malaysia Bhd
KLSE:4863
0.023x
Shanghai Electric Power Co Ltd
SHG:600021
0.127x
Clearwater Analytics Holdings Inc
NYSE:CWAN
0.009x
Silergy Corp
TW:6415
-0.010x
Lottomatica Group SpA
NYSE:LOTMY
0.362x
STAG Industrial Inc
NYSE:STAG
0.041x
Flughafen Zurich
SW:FHZN
0.121x

Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2013–2025)

The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Sartorius Aktiengesellschaft.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €3.87 Billion
≈ $4.52 Billion
€837.00 Million
≈ $978.54 Million
0.216x -13.58%
2024-12-31 €3.90 Billion
≈ $4.56 Billion
€976.20 Million
≈ $1.14 Billion
0.250x -15.90%
2023-12-31 €2.76 Billion
≈ $3.22 Billion
€821.30 Million
≈ $960.19 Million
0.298x +7.84%
2022-12-31 €2.66 Billion
≈ $3.11 Billion
€734.20 Million
≈ $858.36 Million
0.276x -45.60%
2021-12-31 €1.72 Billion
≈ $2.01 Billion
€873.20 Million
≈ $1.02 Billion
0.508x +39.15%
2020-12-31 €1.40 Billion
≈ $1.64 Billion
€511.52 Million
≈ $598.03 Million
0.365x +4.57%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€377.19 Million
≈ $440.97 Million
0.349x +38.87%
2018-12-31 €973.39 Million
≈ $1.14 Billion
€244.52 Million
≈ $285.87 Million
0.251x -1.89%
2017-12-31 €806.56 Million
≈ $942.95 Million
€206.51 Million
≈ $241.43 Million
0.256x +10.70%
2016-12-31 €736.80 Million
≈ $861.40 Million
€170.42 Million
≈ $199.24 Million
0.231x +18.96%
2015-12-31 €644.75 Million
≈ $753.78 Million
€125.36 Million
≈ $146.56 Million
0.194x -25.39%
2014-12-31 €497.66 Million
≈ $581.82 Million
€129.69 Million
≈ $151.62 Million
0.261x +13.63%
2013-12-31 €450.25 Million
≈ $526.39 Million
€103.26 Million
≈ $120.72 Million
0.229x --

About Sartorius Aktiengesellschaft

F:SRT Germany Medical Instruments & Supplies
Market Cap
$7.20 Billion
€6.16 Billion EUR
Market Cap Rank
#2868 Global
#563 in Germany
Share Price
€179.80
Change (1 day)
-2.71%
52-Week Range
€146.60 - €205.00
All Time High
€829.87
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more